Vitamin D levels do not cause vitamin-drug interactions with dexamethasone or dasatinib in mice.
Vitamin D3 (VD3) induces intestinal CYP3A that metabolizes orally administered anti-leukemic chemotherapeutic substrates dexamethasone (DEX) and dasatinib potentially causing a vitamin-drug interaction. To determine the impact of VD3 status on systemic exposure and efficacy of these chemotherapeutic...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/2b256692a0f8435c85bc1753e5748a00 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!